Cholinesterase Inhibitor Utilization Patterns: Just Because It Can Be Counted Does Not Mean It Counts

por Starner, Catherine I., Gleason, Patrick P.
Publicado 2008

Drug super spender tsunami: An integrated medical and pharmacy benefits assessment

por Starner, Catherine I, Bowen, Kevin, Gleason, Patrick P
Publicado 2022

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis

por Marshall, Landon Z, Espinosa, Rachel, Starner, Catherine I, Gleason, Patrick P
Publicado 2023

Association of a Controlled Substance Scoring Algorithm with Health Care Costs and Hospitalizations: A Cohort Study

por Starner, Catherine I., Qiu, Yang, Karaca-Mandic, Pinar, Gleason, Patrick P.
Publicado 2016

Pharmacy Students' Views of Managed Care Pharmacy and PBMs: Should There Be More Exposure to Managed Care in the Pharmacy Curriculum?

por Pittenger, Amy L., Starner, Catherine I., Thompson, Kaj, Gleason, Patrick P.
Publicado 2010

Rosiglitazone Prior Authorization Safety Policy: A Cohort Study

por Starner, Catherine I., Fenrick, Beckie, Coleman, John, Wickersham, Peter, Gleason, Patrick P.
Publicado 2012

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events

por Starner, Catherine I., Schafer, Jeremy A., Heaton, Alan H., Gleason, Patrick P.
Publicado 2008

Dalfampridine Prior Authorization Program: A Cohort Study

por Gleason, Patrick P., Phillips, Jill, Fenrick, Beckie A., Delgado-Riley, Ana, Starner, Catherine I.
Publicado 2013

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications

por Gleason, Patrick, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Sarran, H. Scott
Publicado 2009

Generic Drug Discount Programs: Are Prescriptions Being Submitted for Pharmacy Benefit Adjudication?

por Tungol, Alexandra, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Qiu, Yang, Gleason, Patrick P.
Publicado 2012

Health Plan Utilization and Costs of Specialty Drugs Within 4 Chronic Conditions

por Gleason, Patrick P., Alexander, G. Caleb, Starner, Catherine I., Ritter, Stephen T., Van Houten, Holly K., Gunderson, Brent W., Shah, Nilay D.
Publicado 2013